# Fulcrum Therapeutics, Inc.: Form 8-K, filed Nov 12, 2024

- Company: [Fulcrum Therapeutics, Inc.](/companies/fulc.md) (CIK 1680581)
- Form: 8-K
- Filed: 2024-11-12
- Accepted by EDGAR: Nov 12, 2024, 17:21 ET
- Period: 2024-11-12
- Accession: 0001193125-24-256101
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1680581/000119312524256101/d875361d8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1680581/000119312524256101/

## Items reported

- Item 5.02: Departure or appointment of officers or directors

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1680581/000119312524256101/d875361d8k.htm

Filed Nov 12, 2024.
Source: SEC EDGAR, the filing index for accession 0001193125-24-256101. Last ingested by Listed: Nov 14, 2026, 23:09 ET. No prices; not investment advice.
